NASDAQ: MNMDMind Medicine Inc Stock Ownership - Who owns Mind Medicine?
Insider buying vs selling
Have Mind Medicine Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert Barrow | Chief Executive Officer | 2023-09-25 | 8,231 | $3.58 | $29.47kSell |
| Dan Karlin | Chief Medical Officer | 2023-09-25 | 3,678 | $3.57 | $13.13kSell |
| Dan Karlin | Chief Medical Officer | 2023-09-25 | 3,240 | $3.58 | $11.60kSell |
| Schond L. Greenway | Chief Financial Officer | 2023-09-25 | 1,908 | $3.57 | $6.81kSell |
| Schond L. Greenway | Chief Financial Officer | 2023-09-25 | 3,854 | $3.58 | $13.80kSell |
| Robert Barrow | Chief Executive Officer | 2023-09-25 | 5,268 | $3.57 | $18.81kSell |
| Schond L. Greenway | Chief Financial Officer | 2023-08-25 | 20,000 | $3.80 | $76.00kSell |
| Dan Karlin | Chief Medical Officer | 2023-06-27 | 3,820 | $3.19 | $12.19kSell |
| Robert Barrow | Chief Executive Officer | 2023-06-27 | 7,086 | $3.19 | $22.60kSell |
| Schond L. Greenway | Chief Financial Officer | 2023-06-27 | 7,694 | $3.19 | $24.54kSell |
MNMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MNMD insiders and whales buy or sell their stock.
MNMD Shareholders
What type of owners hold Mind Medicine Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Stephen L. Hurst | 102.53% | 40,722,778 | $147.42M | Insider |
| Cynthia W. Hu | 3.02% | 1,200,000 | $4.34M | Insider |
| Alyeska Investment Group LP | 2.01% | 796,962 | $2.89M | Institution |
| Robert Barrow | 1.54% | 611,729 | $2.21M | Insider |
| Vanguard Group Inc | 1.43% | 567,885 | $2.06M | Institution |
| Blackrock Inc | 1.39% | 553,312 | $2.00M | Institution |
| Dan Karlin | 0.94% | 371,804 | $1.35M | Insider |
| Geode Capital Management LLC | 0.93% | 371,010 | $1.34M | Institution |
| Busey Wealth Management | 0.62% | 244,347 | $884.54k | Institution |
| Schond L. Greenway | 0.56% | 222,269 | $804.61k | Insider |
MNMD vs Biotech Stocks
Mind Medicine Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.